Xeomin 50 enheter Pulver till injektionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

xeomin 50 enheter pulver till injektionsvätska, lösning

merz pharmaceuticals gmbh - clostridium botulinum typ a neurotoxin - pulver till injektionsvätska, lösning - 50 enheter - sackaros hjälpämne; clostridium botulinum typ a neurotoxin 50 e aktiv substans - botulinum toxin

Xeomin 200 enheter Pulver till injektionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

xeomin 200 enheter pulver till injektionsvätska, lösning

merz pharmaceuticals gmbh - clostridium botulinum typ a neurotoxin - pulver till injektionsvätska, lösning - 200 enheter - sackaros hjälpämne; clostridium botulinum typ a neurotoxin 200 e aktiv substans

Isovorin 10 mg/ml Injektionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

isovorin 10 mg/ml injektionsvätska, lösning

pfizer ab - kalciumlevofolinathydrat - injektionsvätska, lösning - 10 mg/ml - kalciumlevofolinathydrat aktiv substans - kalciumlevofolinat

Spikevax (previously COVID-19 Vaccine Moderna) Europeiska unionen - svenska - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Ondansetron Kalceks 2 mg/ml Injektions-/infusionsvätska, lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ondansetron kalceks 2 mg/ml injektions-/infusionsvätska, lösning

as kalceks - ondansetronhydrokloriddihydrat - injektions-/infusionsvätska, lösning - 2 mg/ml - ondansetronhydrokloriddihydrat 2,494 mg aktiv substans

Pregabalin Medical Valley 150 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pregabalin medical valley 150 mg kapsel, hård

medical valley invest ab - pregabalin - kapsel, hård - 150 mg - laktosmonohydrat hjälpämne; pregabalin 150 mg aktiv substans

Pregabalin Medical Valley 75 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pregabalin medical valley 75 mg kapsel, hård

medical valley invest ab - pregabalin - kapsel, hård - 75 mg - laktosmonohydrat hjälpämne; pregabalin 75 mg aktiv substans

Pregabalin Medical Valley 50 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pregabalin medical valley 50 mg kapsel, hård

medical valley invest ab - pregabalin - kapsel, hård - 50 mg - laktosmonohydrat hjälpämne; pregabalin 50 mg aktiv substans

Pregabalin Medical Valley 200 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pregabalin medical valley 200 mg kapsel, hård

medical valley invest ab - pregabalin - kapsel, hård - 200 mg - pregabalin 200 mg aktiv substans; laktosmonohydrat hjälpämne

Pregabalin Medical Valley 100 mg Kapsel, hård Sverige - svenska - Läkemedelsverket (Medical Products Agency)

pregabalin medical valley 100 mg kapsel, hård

medical valley invest ab - pregabalin - kapsel, hård - 100 mg - laktosmonohydrat hjälpämne; pregabalin 100 mg aktiv substans